ZUTRA
LIVE

Serial Number

79337353

Owner

OPTICA LIFE ACCESSORIES LIMITED

Attorney

Marlene J. Williams

Filing Date

Dec 13, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ZUTRA Trademark

Serial Number: 79337353 • Registration: 7077623

ZUTRA is a trademark filed by OPTICA LIFE ACCESSORIES LIMITED on December 13, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods). The application is currently registered and active.

Owner Contact Info

OPTICA LIFE ACCESSORIES LIMITED (5 trademarks)

8 Moncur Place,

Entity Type: 99

Trademark Details

Filing Date

December 13, 2021

Registration Date

June 13, 2023

Published for Opposition

March 28, 2023

Goods & Services

Nutraceuticals for use as a dietary supplement; nutraceuticals for the treatment of inflammation, brain function, cholesterol, immune system, eye health, nervous system, respiratory health, cardiovascular health, triglyceride levels and joint pain; nutraceuticals for medical purposes, specifically, for the treatment of inflammation, brain function, cholesterol, immune system, eye health, nervous system, respiratory health, cardiovascular health, triglyceride levels and joint pain; dietary supplements; vitamins; herbal supplements; mineral supplements; dietary food supplements for medical use; dietary foods for medical use, namely, nutritional drinks, supplemental drinks and powdered dietary food supplements; dietary nutritional supplements for medical use; dietary supplements for humans; dietary supplements for humans and animals; dietary supplements for medical use; food supplements for the dietary management of illness in humans; oils for use as a dietary supplement, namely, krill oil and mussel oil; powders for use as a dietary supplement, namely, mussel powder; calcium supplements; vitamins for humans and animals; dietary supplements for animals and pets; pharmaceutical preparations and substances for the treatment of inflammation, brain function, cholesterol, immune system, eye health, nervous system, respiratory health, cardiovascular health, triglyceride levels and joint pain; pharmaceutical preparations and substances containing fish oils for the treatment of inflammation, brain function, cholesterol, immune system, eye health, nervous system, respiratory health, cardiovascular health, triglyceride levels and joint pain; dietetic food and beverages adapted for medical use; cod liver oil; nutritional supplements; vitamin and mineral supplements; nutritional supplements containing vitamins, minerals, trace elements and/or essential fatty acids including fish oils, provided in capsule, solid, liquid or tablet form; nutritional complements in the nature of nutritional supplements for medical use; preparations in the nature of vitamin and mineral supplements consisting of minerals, vitamins, trace elements and/or essential fatty acids including fish oils for use as additives for food; slimming aids and preparations in the nature of slimming pills for medical use including meal replacement preparations in capsule, liquid or gel form; antibiotics; anti-inflammatory preparations and balms for medical purposes; nutritional preparations and substances in the nature of nutritional supplements adapted for medical use; edible oils and fats adapted for medical use, namely, edible fish oil; dietetic foods and food preparations adapted for medical use, namely, nutritional drinks, supplemental drinks and powdered dietary food supplements; dietetic beverages and drinks adapted for medical use; dietary supplements; food supplements; mineral food supplements; mineral water salts for medical purposes; mineral water for medicinal use; nutritional additives in the nature of dietary supplements for medical use; medicinal oils; medicinal preparations and food supplements for slimming purposes; vitamin and mineral preparations, supplements and substances adapted for medical use; veterinary preparations and substances including those containing fish oil for the treatment of inflammation, brain function, cholesterol, immune system, eye health, nervous system, respiratory health, cardiovascular health, triglyceride levels and joint pain; sanitary preparations and substances including those containing fish oils for medical use

Prepared and packaged meals consisting primarily of processed fish, seafood or algae in liquid, solid, gel or liquid form for human consumption; dried milk and rice based meal replacement preparations not for medical purposes, namely rice milk, rice milk powder in liquid, solid, gel or liquid form; health foods and food supplements not for medical purposes, namely, prepared and packaged meals consisting primarily of preserved, dried, and cooked vegetables, fruit, nut or meat; snack foods, namely, snack bars, chilled foods, oils for food, food pastes, frozen meals and tinned food consisting primarily of preserved, dried, and cooked vegetables, fruit, nut or meat; foodstuffs rich in proteins, based on meat, fish, vegetables and dairy for human consumption, namely, snack bars, chilled foods, oils for food, food pastes, frozen meals and tinned food; preserved, dried and cooked fruits, nuts and vegetables; edible oils and fats; extracts of processed fish, shellfish or algae for nutritional purposes, specifically for use in prepared meals or food; fruit preserves; instant meals in the nature of prepared and pre-packaged meals consisting primarily of preserved, dried, and cooked vegetables, fruit, nut or meat

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 5, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 10, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 18, 2023 FICS
FINAL DISPOSITION PROCESSED
Sep 18, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 13, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 13, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 13, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 28, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 28, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 8, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 21, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 21, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 21, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 21, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 21, 2023 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Feb 21, 2023 ZZZX
WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST
Feb 21, 2023 PBER
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 21, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 21, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 21, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 21, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 21, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 25, 2023 TROA
REFUSAL PROCESSED BY IB
Jan 9, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 17, 2022 RFCS
REFUSAL PROCESSED BY MPU
Dec 16, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 5, 2022 RFCR
NON-FINAL ACTION WRITTEN
Oct 4, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 20, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 12, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 7, 2022 REPR